Compare TVTX & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TVTX | URBN |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 6.2B |
| IPO Year | 2013 | 1995 |
| Metric | TVTX | URBN |
|---|---|---|
| Price | $65.28 | $81.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | $40.62 | ★ $86.91 |
| AVG Volume (30 Days) | 1.2M | ★ 1.3M |
| Earning Date | 05-04-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.89 | 18.78 |
| EPS | N/A | ★ 1.30 |
| Revenue | N/A | ★ $6,165,376,000.00 |
| Revenue This Year | $44.76 | $10.67 |
| Revenue Next Year | $35.51 | $7.01 |
| P/E Ratio | ★ N/A | $61.95 |
| Revenue Growth | N/A | ★ 11.07 |
| 52 Week Low | $22.06 | $59.54 |
| 52 Week High | $68.03 | $85.43 |
| Indicator | TVTX | URBN |
|---|---|---|
| Relative Strength Index (RSI) | 60.45 | 57.34 |
| Support Level | $53.76 | $67.23 |
| Resistance Level | $66.24 | $84.57 |
| Average True Range (ATR) | 1.98 | 2.99 |
| MACD | -0.14 | 0.22 |
| Stochastic Oscillator | 71.85 | 63.93 |
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
Founded in 1970, Philadelphia-based Urban Outfitters is a multibrand apparel and home goods retailer that operates nearly 800 stores and e-commerce in the US, which accounts for about 87% of sales, as well as in other regions. Its retail nameplates are Urban Outfitters (22% of fiscal 2026 sales), Free People/Movement (26%), and Anthropologie (42%). Retail accounted for 86% of fiscal 2026 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (9% of sales). Urban Outfitters primarily markets to young adults and offers products across apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.